Albert Friesen
Chief Executive Officer bei MEDICURE INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Albert D.
Friesen is the founder of Viventia Biotech, Inc. (founded in 1995), Medicure, Inc. (founded in 1997), Luminor Medical Technologies, Inc. (founded in 1998), and Genesys Venture, Inc. (founded in 1997).
He holds the title of Chairman & Chief Executive Officer at Medicure, Inc., Chairman at Luminor Medical Technologies, Inc., and President at Genesys Venture, Inc. Dr. Friesen was also the founder of Winnipeg RH Institute Foundation, Inc., ABI Biotechnology, Inc., Genesys Pharma, Inc., KAM Scientific, Inc., and Industrial Biotechnology Association of Canada.
His current job(s) include Chief Executive Officer at CentreStone Ventures, Inc. (since 2006), Chairman, President & Chief Executive Officer at Marsala Biotech Inc, Co-Chairman at Manitoba Innovation Council, Chairman at Waverley Pharma, Inc. (since 2016), Director at Mylan API, Inc., Director at Magellan Biotech, Inc., Director at Canada Foundation for Innovation (since 2010), and Director at Sensible Medical Innovations Ltd.
(since 2019).
His former job(s) include Chief Executive Officer & Director at Big Sky Petroleum Corp.
(2006-2008), CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc., Chairman at Kane Biotech, Inc. (2001-2011), Director at DiaMedica Therapeutics, Inc. (2007-2008), Director at MEDA Investments, Inc. (2000-2012), Director at Waverley Pharma, Inc., and Member-Industrial Advisory Committee at Biotechnology Research Corp.Dr. Friesen obtained a doctorate degree from the University of Manitoba.
Dr. Friesen is also the founder of Winnipeg RH Institute Foundation, Inc., ABI Biotechnology, Inc., Genesys Pharma, Inc., KAM Scientific, Inc., Industrial Biotechnology Association of Canada.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MEDICURE INC.
24,94% | 11.01.2024 | 2 602 955 ( 24,94% ) | 2 Mio $ | 31.03.2024 |
WAVERLEY PHARMA, INC.
74,61% | 08.05.2023 | 40 292 000 ( 74,61% ) | 967 008 $ | 31.03.2024 |
Aktive Positionen von Albert Friesen
Unternehmen | Position | Beginn |
---|---|---|
MEDICURE INC. | Chief Executive Officer | 15.09.1997 |
WAVERLEY PHARMA INC. | Chairman | 14.12.2016 |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Chief Executive Officer | 01.01.2006 |
Mylan API, Inc.
Mylan API, Inc. Pharmaceuticals: MajorHealth Technology Mylan API, Inc. engages in manufacturing and development of Active Pharmaceutical Ingredients. The company was founded in 2014 and is headquartered in Somerset, NJ. | Director/Board Member | - |
Marsala Biotech Inc
Marsala Biotech Inc BiotechnologyHealth Technology Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada. | Chief Executive Officer | - |
Manitoba Innovation Council | Chairman | 20.05.2011 |
Canada Foundation For Innovation | Director/Board Member | 16.02.2010 |
Magellan Biotech, Inc.
Magellan Biotech, Inc. Financial ConglomeratesFinance Magellan Biotech, Inc. provides private equity services to biotechnology companies. | Director/Board Member | 25.11.2009 |
Genesys Venture, Inc.
Genesys Venture, Inc. Financial ConglomeratesFinance Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada. | Founder | 01.01.1997 |
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Albert Friesen
Unternehmen | Position | Ende |
---|---|---|
░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Albert Friesen
University of Manitoba | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MEDICURE INC. | Health Technology |
KANE BIOTECH INC. | Commercial Services |
DIAMEDICA THERAPEUTICS INC. | Health Technology |
WAVERLEY PHARMA INC. | Health Technology |
Private Unternehmen | 20 |
---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
Mylan API, Inc.
Mylan API, Inc. Pharmaceuticals: MajorHealth Technology Mylan API, Inc. engages in manufacturing and development of Active Pharmaceutical Ingredients. The company was founded in 2014 and is headquartered in Somerset, NJ. | Health Technology |
Magellan Biotech, Inc.
Magellan Biotech, Inc. Financial ConglomeratesFinance Magellan Biotech, Inc. provides private equity services to biotechnology companies. | Finance |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba. | Finance |
Biotechnology Research Corp.
Biotechnology Research Corp. Miscellaneous Commercial ServicesCommercial Services Part of The Hong Kong University of Science & Technology, Biotechnology Research Corp. engages in biotechnology research and development. The private company is based in Hong Kong, Hong Kong. | Commercial Services |
Industrial Biotechnology Association of Canada | |
Genesys Venture, Inc.
Genesys Venture, Inc. Financial ConglomeratesFinance Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada. | Finance |
Canada Foundation For Innovation | Miscellaneous |
Winnipeg RH Institute Foundation, Inc. | |
ABI Biotechnology, Inc. | |
Genesys Pharma, Inc. | |
KAM Scientific, Inc.
KAM Scientific, Inc. Chemicals: AgriculturalProcess Industries KAM Scientific, Inc. manufactures and distributes microbial disinfectant spray solutions for laboratories, hospitals, dental offices, clinics and various medical and public health related facilities. It offers Virocidin-X, a disinfectant and deodorizer for cleaning bacteria, fungus, and viruses. The company was founded by Albert D. Friesen and is headquartered in Winnipeg, Canada. | Process Industries |
MEDA Investments, Inc.
MEDA Investments, Inc. Investment ManagersFinance MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis. | Finance |
Sensible Medical Innovations Ltd.
Sensible Medical Innovations Ltd. Electronic Equipment/InstrumentsElectronic Technology Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel. | Electronic Technology |
Manitoba Innovation Council | |
Big Sky Petroleum Corp.
Big Sky Petroleum Corp. Oil & Gas ProductionEnergy Minerals Big Sky Petroleum Corp. is an oil and gas exploration and production company with operations in Montana and Texas. It is focused on the development of unconventional tight oil reservoirs in the Southern Alberta Basin of Montana and the Southern Midland Basin in West Texas. The company was founded on February 3, 2006 and is headquartered in Vancouver, Canada. | Energy Minerals |
Buffalo Capital, Inc.
Buffalo Capital, Inc. Financial ConglomeratesFinance Buffalo Capital, Inc. engages in the identification and evaluation of interest in properties, assets or businesses. The company was founded on December 14, 2016 and is headquartered in Winnipeg, Canada. | Finance |
Marsala Biotech Inc
Marsala Biotech Inc BiotechnologyHealth Technology Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada. | Health Technology |
Waverley Pharma, Inc. /Old/
Waverley Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Waverley Pharma, Inc. operates as a specialty pharmaceutical company. It develops and commercializes safe and small molecules for treatment of cancer. The firm's products include WAV-101, WAV-102 and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada. | Health Technology |